TesoRx is a privately held pharmaceutical company developing a first-in-class unmodified oral testosterone for androgen deficiency. It is in the process of completing a phase two clinical study and is on track to commence dosing for phase three by early 2026.
Company Details
- Founded
- -
- Address
- 325 Sharon Park Dr,
- Phone
- 650-561-3330
- in****@****orx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tesorx.com
- HQ
- Menlo Park, California
Tesorx Pharma, Llc Questions
Tesorx Pharma, Llc's helpline number is 650-561-3330
Tesorx Pharma, Llc's website is tesorx.com
Tesorx Pharma, Llc's LinkedIn profile is https://www.linkedin.com/company/tesorx-pharma-llc
Tesorx Pharma, Llc's industry is
Biotechnology Research
Tesorx Pharma, Llc's top competitors are
Kinopharma,
Theraduty,
Valley Fever Solutions,
Apt Therapeutics,
Magqu Co., Ltd.,
Lipac Oncology, Inc.,
Seawolf Therapeutics, Inc.,
Sage-N Research, Inc.,
Anonox Gmbh,
Arcturus Therapeutics.
Tesorx Pharma, Llc's support email address is info@tesorx.com
Tesorx Pharma, Llc's categories are Biotechnology Research
Tesorx Pharma, Llc's founding year is 2010
